Guided since its establishment by the Bianchini Saetti family, Opocrin is now a leading player in pharmaceutical research and development, manufacture and marketing of active pharmaceutical ingredients and new therapeutic solutions.
Its international dimension has not changed its “big family” spirit, which focuses on people to build a fairer and more sustainable future. With proudly Modenese roots, European quality and a global outlook.
Mara Bianchini
President
“We strongly believe in continuity: to grow and expand in the global market we maintain the same spirit and the same propensity to innovation”
Federico Saetti
CEO, Vice-President
“At Opocrin, we act as a single body, looking in the same direction and growing together, every day”
Enrica Bovina
Chief R&D and quality officer
“An innovation-oriented approach: we strive to demonstrate new opportunities for the development and use of heparin and its derivatives. And open up new therapeutic options.”
